Dextran Conjugation of Non–Steroidal Anti-Inflammatory Drug (Etodolac): A Colon Targeting Approach: Development of a Glucosamine-conjugated Etodolac Prodrug for Improved Targeting and Reduced Side Effects. JASRAE. 2019;16(6):3589-3595. Accessed April 4, 2026. https://ignited.in/index.php/jasrae/article/view/11970